Vulnerability to shear stress caused by altered peri-endothelial matrix is a key feature of Moyamoya disease

Muneaki Matsuo1, Satomi Nadanaka2, Minami Soga3

  • 1Department of Pediatrics, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan. matsuo@cc.saga-u.ac.jp.

Scientific Reports
|January 16, 2021
PubMed

Insights

Moyamoya disease (MMD) involves thickened blood vessels due to abnormal glycosaminoglycan accumulation, particularly hyaluronan and chondroitin sulfate (CS). This altered matrix makes endothelial cells vulnerable, leading to stenosis.

Area of Science:

  • Vascular Biology
  • Biochemistry
  • Genetics

Background:

  • Moyamoya disease (MMD) is a progressive cerebrovascular disorder characterized by stenosis in the terminal internal carotid arteries.
  • The exact pathogenesis of MMD remains unclear, despite the identification of RNF213 as a susceptibility gene.

Purpose of the Study:

  • To investigate the role of glycosaminoglycans (GAGs), specifically hyaluronan and chondroitin sulfate (CS), in the pathogenesis of Moyamoya disease.
  • To explore the relationship between endothelial progenitor cells, extracellular matrix composition, and vascular stenosis in MMD.

Main Methods:

  • Immunohistochemical analysis of autopsy specimens from an MMD patient and controls.
  • Analysis of glycosaminoglycans in endothelial cells derived from MMD and control induced pluripotent stem cells.
  • Computational fluid dynamics modeling to assess wall shear stress in the internal carotid artery.

Main Results:

  • MMD lesions showed marked accumulation of hyaluronan and CS in the thickened intima, with high hyaluronan synthase 2 expression in endothelial progenitor cells.
  • MMD endothelium exhibited minimal staining for CS and hyaluronan compared to controls.
  • Endothelial cells from MMD patients had reduced amounts of CS, especially sulfated CS.
  • Computational fluid dynamics identified high wall shear stress in the predisposing arterial region for MMD.

Conclusions:

  • Altered peri-endothelial extracellular matrix composition, including excessive hyaluronan and CS production by invading endothelial progenitor cells, may contribute to endothelial vulnerability and vascular stenosis in Moyamoya disease.
  • These findings suggest a novel mechanism involving GAG dysregulation in MMD pathogenesis.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
389
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
153
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
188
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
163